Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Diagnosis and treatment of hyponatraemia.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.

Pages